183 related articles for article (PubMed ID: 18843889)
21. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
[TBL] [Abstract][Full Text] [Related]
22. Temporal changes in bacterial resistance in German intensive care units, 2001-2003: data from the SARI (surveillance of antimicrobial use and antimicrobial resistance in intensive care units) project.
Meyer E; Schwab F; Jonas D; Ruden H; Gastmeier P; Daschner FD
J Hosp Infect; 2005 Aug; 60(4):348-52. PubMed ID: 15923060
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial resistance in Escherichia coli and Pseudomonas aeruginosa from Intensive Care Units in The Netherlands, 1998-2005.
Oudhuis GJ; Verbon A; Hoogkamp-Korstanje JA; Stobberingh EE;
Int J Antimicrob Agents; 2008 Jan; 31(1):58-63. PubMed ID: 17961989
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study.
Walkty A; Decorby M; Nichol K; Mulvey MR; Hoban D; Zhanel G;
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):217-21. PubMed ID: 18304774
[TBL] [Abstract][Full Text] [Related]
25. Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private, university-affiliated teaching hospital: an 8-year-experience: 1995-2002.
Mohr JF; Jones A; Ostrosky-Zeichner L; Wanger A; Tillotson G
Int J Antimicrob Agents; 2004 Oct; 24(4):346-51. PubMed ID: 15380259
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).
Mutnick AH; Rhomberg PR; Sader HS; Jones RN
J Antimicrob Chemother; 2004 Feb; 53(2):290-6. PubMed ID: 14711839
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial susceptibility patterns in Pseudomonas aeruginosa: data from a multicenter Intensive Care Unit Surveillance Study (ISS) in the United States.
Friedland I; Gallagher G; King T; Woods GL
J Chemother; 2004 Oct; 16(5):437-41. PubMed ID: 15565908
[TBL] [Abstract][Full Text] [Related]
28. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
[TBL] [Abstract][Full Text] [Related]
29. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
[TBL] [Abstract][Full Text] [Related]
30. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
Gad GF; El-Domany RA; Zaki S; Ashour HM
J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
[TBL] [Abstract][Full Text] [Related]
31. Emergence of ciprofloxacin-resistant pseudomonas in chronic suppurative otitis media.
Jang CH; Park SY
Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):321-3. PubMed ID: 15270816
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM
J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
[TBL] [Abstract][Full Text] [Related]
33. Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital's intensive care and intermediate care units.
Lewis GJ; Fang X; Gooch M; Cook PP
Infect Control Hosp Epidemiol; 2012 Apr; 33(4):368-73. PubMed ID: 22418632
[TBL] [Abstract][Full Text] [Related]
34. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
[TBL] [Abstract][Full Text] [Related]
35. [Resistance to antibiotic treatment produced in a model of experimental Pseudomonas aeruginosa peritonitis].
Froidefond S; Saivin S; Lemozy J; Marchou B; Auvergnat JC; Dabernat H
Pathol Biol (Paris); 1992 May; 40(5):573-82. PubMed ID: 1495846
[TBL] [Abstract][Full Text] [Related]
36. Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents.
Cook PP; Das TD; Gooch M; Catrou PG
Infect Control Hosp Epidemiol; 2008 Aug; 29(8):716-22. PubMed ID: 18590455
[TBL] [Abstract][Full Text] [Related]
37. Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics.
Khan JA; Iqbal Z; Rahman SU; Farzana K; Khan A
Pak J Pharm Sci; 2008 Jul; 21(3):311-5. PubMed ID: 18614431
[TBL] [Abstract][Full Text] [Related]
38. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002.
Obritsch MD; Fish DN; MacLaren R; Jung R
Antimicrob Agents Chemother; 2004 Dec; 48(12):4606-10. PubMed ID: 15561832
[TBL] [Abstract][Full Text] [Related]
39. Ciprofloxacin-resistant Pseudomonas keratitis.
Garg P; Sharma S; Rao GN
Ophthalmology; 1999 Jul; 106(7):1319-23. PubMed ID: 10406614
[TBL] [Abstract][Full Text] [Related]
40. Contribution of clonal dissemination and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit setting.
Juan C; Gutiérrez O; Oliver A; Ayestarán JI; Borrell N; Pérez JL
Clin Microbiol Infect; 2005 Nov; 11(11):887-92. PubMed ID: 16216103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]